Panorama Research Incorporated

Panorama Research Incorporated is a for-profit biotech company located in Sunnyvale, California, specializing in advanced medical research and therapeutic development. Registered in SAM.gov since 2005, the company focuses on innovative biotechnology solutions, particularly in developing novel antibody-based therapies and immunotherapies targeting complex medical conditions. The organization leverages its expertise in antibody humanization, cell line development, and preclinical research to create cutting-edge therapeutic interventions across multiple medical domains.

The company has secured multiple federal grants from prestigious agencies including the National Institute on Aging, Defense Health Agency, National Institute of Arthritis and Musculoskeletal and Skin Diseases, and National Institute of Dental and Craniofacial Research. Panorama Research has developed targeted research projects in diverse medical areas such as sarcopenia treatment, ovarian cancer immunotherapy, arthrofibrosis reduction, and neurological disease research involving conditions like amyotrophic lateral sclerosis and frontotemporal dementia. Their grant-funded work involves sophisticated research methodologies including antibody development, in vitro and in vivo characterization, humanization of murine antibodies, and preclinical validation in various disease-specific mouse models. As a subcontractor, they have also provided specialized services like antibody humanization, cell line development, and preclinical pharmacokinetics and toxicology studies, demonstrating a comprehensive approach to advanced medical research and therapeutic development.